Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764582 · ClinicalTrials.gov registry record · Phase 4
Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery
A Phase 4 study, sponsored by Santen.
- Terminated
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00764582 is a Phase 4 study that was terminated before completion, run by Santen. The registered enrollment target is 60 participants.
The verdict
NCT00764582, a Phase 4 study, was terminated before completion, sponsored by Santen.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)
Interventions
- DRUG 1.5% levofloxacin ophthalmic solution
- DRUG 0.5% moxifloxacin ophthalmic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764582
The ClinicalTrials.gov registry entry for NCT00764582 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Santen, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1.5% levofloxacin ophthalmic solution is the first listed.
NCT00764582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00764582 about?
NCT00764582 is a clinical study titled "Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery". Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)
What is the current status of trial NCT00764582?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2008-09.
What interventions are being tested in trial NCT00764582?
The interventions under investigation include: 1.5% levofloxacin ophthalmic solution (DRUG), 0.5% moxifloxacin ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT00764582?
This trial is sponsored by Santen, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.